CENTESSA PHARMACEUTICALS
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry-leading teams. Each program is developed by a Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team.
CENTESSA PHARMACEUTICALS
Industry:
Biotechnology Pharmaceutical
Founded:
2021-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.centessa.com
Total Employee:
11+
Status:
Active
Contact:
617.468.5770
Email Addresses:
[email protected]
Total Funding:
550 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API LetsEncrypt WordPress Font Awesome Domain Not Resolving Wordpress Plugins Nginx Sitelinks Search Box
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Obsidian Therapeutics
Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
Oberland Capital
Oberland Capital investment in Post-IPO Debt - Centessa Pharmaceuticals
Franklin Templeton Investments
Franklin Templeton Investments investment in Series A - Centessa Pharmaceuticals
Logos Capital
Logos Capital investment in Series A - Centessa Pharmaceuticals
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series A - Centessa Pharmaceuticals
BVF Partners
BVF Partners investment in Series A - Centessa Pharmaceuticals
Cormorant Asset Management
Cormorant Asset Management investment in Series A - Centessa Pharmaceuticals
Boxer Capital
Boxer Capital investment in Series A - Centessa Pharmaceuticals
Wellington Management
Wellington Management investment in Series A - Centessa Pharmaceuticals
Vida Ventures
Vida Ventures investment in Series A - Centessa Pharmaceuticals
T. Rowe Price
T. Rowe Price investment in Series A - Centessa Pharmaceuticals
Key Employee Changes
Official Site Inspections
http://www.centessa.com Semrush global rank: 1.55 M Semrush visits lastest month: 16.86 K
- Host name: 95.70.73.34.bc.googleusercontent.com
- IP address: 34.73.70.95
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Centessa Pharmaceuticals"
Corporate Overview - investors.centessa.com
Centessa reported $518.4 million in cash, cash equivalents and short-term investments as of September 30, 2024. Cash runway estimated into mid2027. - 4 Our Most Advanced Potential …See details»
Centessa Pharmaceuticals - Crunchbase Company …
Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated …See details»
About Us - Centessa Pharmaceuticals
Mission Centessa aims to discover and develop medicines that are transformational for patients. Our portfolio of innovative assets, combined with our data-driven decision-making and passionate team of scientists, provide …See details»
Team - Centessa Pharmaceuticals
We are leaders, innovators, and scientists aiming to pursue medicines that are transformational for patients. Executive Team Saurabh Saha, MD, PhD Chief Executive Officer and Director …See details»
Centessa Pharmaceuticals plc - AnnualReports.com
Centessa Pharmaceuticals plc is a clinical-stage pharmaceutical company with a Research & Development innovation engine that aims to discover, develop and ultimately deliver impactful medicines to patients. Their programs span …See details»
Investors | Centessa Pharmaceuticals
Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update. Nov 04, 2024 Centessa Pharmaceuticals to Participate in Upcoming …See details»
Org Chart Centessa Pharmaceuticals - The Official Board
Organizational Chart of Centessa Pharmaceuticals. Centessa Pharmaceuticals www.centessa.com. has 21 executives +1 857 254 9500; Add an executive. Centessa …See details»
Centessa Pharmaceuticals Company Profile - Office Locations
Oct 29, 2024 Centessa Pharmaceuticals is a biopharmaceutical company specializing in drug development. Its programs cover a range of high-value therapeutic areas including oncology, …See details»
Centessa Pharmaceuticals - Funding, Financials, Valuation
Centessa Pharmaceuticals is registered under the ticker FRA:260 . Centessa Pharmaceuticals is funded by 16 investors. Oberland Capital and Franklin Templeton are the most recent …See details»
Centessa Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Centessa Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... About. Centessa Pharmaceuticals has 12 current …See details»
Centessa Pharmaceuticals - Overview, News & Similar companies ...
Apr 23, 2024 Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- …See details»
Centessa Pharmaceuticals Strengthens Executive Leadership with ...
Jun 10, 2024 To best position Centessa for this pivotal time, we’ve added key new talent to lead our finance organization and have enhanced our strategic focus on business development,” …See details»
Executive Team - Tia Bush - Centessa Pharmaceuticals
Tia Bush serves as Chief Technology and Quality Officer for Centessa Pharmaceuticals. Tia is a global leader who brings nearly thirty years of biotechnology quality experience to the …See details»
How Does Centessa Pharmaceuticals Work? - CBM
Oct 2, 2024 Centessa Pharmaceuticals is a cutting-edge biopharmaceutical company that operates on a unique business model, revolutionizing the way pharmaceuticals are developed …See details»
Mission, Vision & Core Values of Centessa Pharmaceuticals
Oct 2, 2024 Centessa Pharmaceuticals is driven by a passion for innovation, collaboration, and excellence. We are committed to fostering a culture of creativity, diversity, and inclusivity, …See details»
Centessa Corporate Governance Guidelines 20.05
Business, government, non-profit or academic organization of high standing. • The nominee shall be highly accomplished in his or her respective field, with superior credentials and recognition. …See details»
Who Owns Centessa Pharmaceuticals – CBM
Oct 2, 2024 [cbm_blg_rlnkng]Centessa Pharmaceuticals is a groundbreaking company in the biopharmaceutical industry that is making waves with its unique ownership structure. Unlike …See details»
Executive Team - Karen Anderson - Centessa Pharmaceuticals
Prior to joining Centessa, Karen was Chief Human Resources Officer at Mimecast Limited. Previously, she was Senior Vice President and Chief Human Resources Officer at Alnylam …See details»
SEC Filing – Centessa Pharmaceuticals
Jun 11, 2021 We have acted as English legal advisers to Centessa Pharmaceuticals plc, a public limited company incorporated in England and Wales with registered number 12973576 …See details»
Centessa: Shift In Focus With ORX750 Development Continues To …
2 days ago According to the 10-Q SEC Filing, Centessa Pharmaceuticals had cash, cash equivalents and short-term investments of $518.4 million as of September 30th of 2024. The …See details»